PatrickJosephGroharMDPhD

Pediatric Hematology & Oncology • Ann Arbor, MI

Associate Professor of Pediatrics Director of Translational Research Center of Childhood Cancer Research Children’s Hospital of Philadelphia University of Pennsylvania Perelman School of Medicine

Join to view full profile

Dr. Grohar is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Grohar's full profile

Already have an account?

Office
1500 E Medical Center Dr
Ann Arbor, MI 48109
Phone+1 734-936-4000

Education & Training

National Cancer InstituteFellowship, Pediatric Hematology/Oncology, 2006 - 2009
Johns Hopkins UniversityResidency, Pediatrics, 2003 - 2006
Wayne State University School of MedicineClass of 2003

Certifications & Licensure

MI State Medical License 2015 - 2025
PA State Medical License 2020 - 2024
TN State Medical License 2011 - 2017
MD State Medical License 2006 - 2012
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

SARC037: A Phase I/II Study to Evaluate the Safety of Trabectedin in Combination With Irinotecan in Ewing Sarcoma Patients Start of enrollment: 2021 Jan 05
Active, not recruiting
Phase 1, Phase 2

Publications & Presentations

PubMed

1 citations
Cell Context Is the Third Axis of Synergy for the Combination of ATR Inhibition and Cisplatin in Ewing Sarcoma.
Jennifer Jess, Katie M Sorensen, Elissa A Boguslawski, Matthew C Stout, Zachary B Madaj
Clinical Cancer Research. 2024-08-15
Long-Term Outcomes in Patients With Localized Ewing Sarcoma Treated With Interval-Compressed Chemotherapy on Children's Oncology Group Study AEWS0031.
Thomas Cash, Mark D Krailo, Allen B Buxton, Bruce R Pawel, John H Healey
Journal of Clinical Oncology. 2023-10-20
2 citations
Children's Oncology Group's 2023 blueprint for research: Bone tumors.
Damon R Reed, Patrick Grohar, Elyssa Rubin, Odion Binitie, Mark Krailo
Pediatric Blood & Cancer. 2023-09-01

Press Mentions

AI Therapeutics Announces the Acquisition of Novel Cancer Drug Candidate EC-8042 (AIT-102)April 24th, 2022
GDF6-CD99 Signaling Regulates Src and Ewing Sarcoma GrowthNovember 3rd, 2020
CHOP Researchers Working Hard to Unlock the Mysteries of Rare Bone CancerNovember 18th, 2019
Join now to see all